Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis
Clinical trial NCT01383590 · COMPLETED
Trial details
- NCT number
- NCT01383590
- Sponsor
- Circassia Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.